Search filters

List of works by Wan-Long Chuang

Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.

scientific article

Alpha‐fetoprotein in patients with hepatocellular carcinoma after transcatheter arterial embolization

scientific article published on November 1, 1992

Anti‐HCV antibody in Chinese cirrhotic patients with or without hepatocellular carcinoma: Relation to multitransfusion

scientific article published on March 1, 1992

Association between gallbladder stones and chronic hepatitis C: Ultrasonographic survey in a hepatitis C and B hyperendemic township in Taiwan

scientific article published on February 20, 2013

Association between virological response and decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in HCV genotype 1: another story

scientific article published on May 1, 2011

Chronic hepatitis C infection in the elderly

scientific article published on November 25, 2011

Chronic hepatitis C infection is associated with insulin resistance and lipid profiles

scientific article published on May 1, 2015

Clinical significance of TT virus (TTV) infection in chronic hepatitis C patients with high dose interferon-alpha therapy in Taiwan: re-evaluated by using new set of TTV primers

scientific article published on October 1, 2003

Clinical utility of host genetic IL‐28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin

scientific article published on September 1, 2013

Coexistence of focal nodular hyperplasia and pseudotumor caused by focal spared lesion in the liver of a young man

scientific article published on 01 November 2003

Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan

scientific article published on August 9, 2010

Dickkopf-1 and hepatocellular carcinoma

scientific article published on October 1, 2012

Duplex pulsed Doppler sonography in the differential diagnosis of hepatocellular carcinoma and other common hepatic tumours

scientific article published on 01 March 1992

Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease

scientific article published on 01 July 2020

Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors' reply

scientific article published on 01 June 2020

GB virus C/hepatitis G virus infection in chronic hepatitis C patients with and without interferon-α therapy

scientific article published on December 1, 2001

Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells

scientific article published on May 9, 2012

Hepatocellular carcinoma cells cause different responses in expressions of cancer‐promoting genes in different cancer‐associated fibroblasts

scientific article published on October 13, 2012

High therapeutic concentration of prazosin up-regulates angiogenic IL6 and CCL2 genes in hepatocellular carcinoma cells

scientific article published on December 23, 2011

Host interleukin-28B genetic variants versus viral kinetics in determining responses to standard-of-care for Asians with hepatitis C genotype 1

scientific article published on December 13, 2011

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients

scientific article published on July 1, 2011

Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin

scientific article published on May 19, 2011

Outcome of patients suffering from a spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure and treated with antivirals

scholarly article by Chia-Yen Dai et al published 27 June 2011 in Hepatology

Pegylated interferon and ribavirin: a therapeutic option in patients who fail to respond to telaprevir-based triple therapy?

scientific article published on August 14, 2013

Pegylated interferon plus ribavirin therapy improves pancreatic β‐cell function in chronic hepatitis C patients

scientific article published on May 17, 2011

Pharmacologic concentrations of melatonin have diverse influence on differential expressions of angiogenic chemokine genes in different hepatocellular carcinoma cell lines

scientific article published on September 25, 2010

Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma

scientific article published on November 25, 2011

Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area

scientific article published on February 1, 1998

Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype

scientific article published on April 1, 2013

Radiotherapy in the treatment of hepatocellular carcinoma and its metastases

scientific article published on January 1, 1992

Relationship between fatty liver, alanine aminotransferase, HBsAg and hepatitis C virus

scientific article published on September 1, 1992

Serial serum VEGF‐A, angiopoietin‐2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization

scientific article published on 08 May 2011

Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients

scientific article published on August 4, 2010

Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up

scientific article published on April 26, 2013

The efficacy and safety of pegylated interferon plus ribavirin combination therapy in chronic hepatitis c patients with hepatocellular carcinoma post curative therapies – A multicenter prospective trial

scientific article published on September 7, 2010

The outcomes of glucose abnormalities in pre‐diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy

scientific article published on February 22, 2012

The response of hepatitis C virus and TT virus to high dose and long duration interferon-alpha therapy in naı̈ve chronic hepatitis C patients

scientific article published on January 1, 2002

The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study

scientific article published on April 15, 1992

The role of hepatitis C virus in chronic hepatitis B virus infection

scientific article published on May 1, 1993

The two different states of hepatitis B virus DNA in asymptomatic carriers: HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers

scientific article published on February 1, 1998

Thyroid autoantibodies and dysfunction do not impact the treatment efficacy of peginterferon and ribavirin combination therapy in chronic hepatitis C

scientific article published on August 18, 2011

Treatment of hepatocellular carcinoma by transcatheter arterial chemoembolization and analysis of prognostic factors

scientific article published on 01 January 1992

Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients

scientific article published on March 19, 2013

Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population

scientific article published on July 7, 2012